Dupixent (dupilumab) was the first biologic treatment approved for atopic dermatitis ... you might be able to stop using steroid creams. However, if needed, you can usually combine biologics ...

Opens in a new tab or window Once-daily roflumilast cream at 0.15% improved symptoms of atopic dermatitis (AD) across multiple end points. According to investigators of the phase 3 studies that ...

The FDA has granted Fast Track designation to rezpegaldesleukin for the treatment of moderate to severe atopic dermatitis.

Atopic dermatitis is a chronic inflammatory skin disease affecting a growing number of people worldwide. Marked by persistent ...

Atopic dermatitis ... These include an injectable biologic medication derived from natural sources and a new non-steroidal topical cream. Additionally, a medication is in development to address ...

With the help of prescription medications and a whole lot of moisturizing, it’s possible to keep dermatitis under control.

Tapinarof, however, offers a potential solution by improving the skin barrier, reducing inflammation and relieving itch ...

A groundbreaking new treatment is EBGLYSS, a biologic therapy which has shown promise in clinical trials for treating moderate to severe atopic dermatitis. EBGLYSS targets specific molecules ...

Incyte’s ruxolitinib franchise, made up of blockbuster JAK inhibitor Jakafi and its topical counterpart Opzelura, have been ...